Miwon Specialty Chemical Co., Ltd.

KRX:268280.KS

155500 (KRW) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q2
Revenue 126,423.811128,576.528129,806.922124,459.96101,486.392112,522.08112,765.153110,899.293136,872.173138,416.539175,850.828160,510.284142,430.809142,240.472130,329.395116,342.37698,864.74786,083.69591,899.65495,141.46590,658.76391,319.06697,952.90197,919.99488,111.98492,902.19692,662.30886,758.19774,478.12686,557.01247,300.53
Cost of Revenue 100,614.562100,882.253103,523.78102,388.48787,209.48498,850.88598,677.70799,200.649115,618.04104,650.035135,004.336124,517.958107,083.748101,537.69295,879.86890,966.58179,267.57669,056.99369,394.18878,358.2774,695.69572,718.97177,119.48781,133.0976,022.20275,341.8773,242.91171,678.38762,961.38268,652.68838,089.078
Gross Profit 25,809.24927,694.27526,283.14322,071.47314,276.90813,671.19514,087.44611,698.64421,254.13333,766.50340,846.49235,992.32635,347.06240,702.78134,449.52825,375.79519,597.17117,026.70222,505.46616,783.19515,963.06818,600.09620,833.41416,786.90412,089.78217,560.32619,419.39715,079.8111,516.74317,904.3249,211.452
Gross Profit Ratio 0.2040.2150.2020.1770.1410.1210.1250.1050.1550.2440.2320.2240.2480.2860.2640.2180.1980.1980.2450.1760.1760.2040.2130.1710.1370.1890.210.1740.1550.2070.195
Reseach & Development Expenses 1,779.44401,055.105896.2911,078.2691,027.6971,099.341,150.91,589.9761,040.9181,070.362936.9691,817.937850.134950.1571,010.4211,436.594890.099971.9991,057.3951,804.6991,118.035985.8871,108.2181,770.175941.3891,013.91,012.9241,535.188913.606688.404
General & Administrative Expenses 197.30411,421.79110,389.9459,808.536236.2797,614.1187,446.7338,096.106200.926141.203210.917180.385247.15150.479101.997125.27875.54881.27370.32177.776204.98192.368219.295233.869238.736175.824192.495184.254134.186191.313134.322
Selling & Marketing Expenses 7,360.1618,153.279-1,423.327-1,375.4615,136.2014,663.4674,443.3394,656.2246,084.6519,566.0869,881.92211,253.3819,196.4857,759.7875,392.4014,546.2994,692.0492,950.923,572.8053,646.3393,542.6993,511.8233,169.3463,072.5883,005.6662,891.0432,801.0773,333.6423,446.463,467.5381,966.763
SG&A 7,557.46511,421.7918,966.6188,433.0756,963.747,614.1187,446.7338,096.1066,285.5769,707.28910,092.83911,433.7669,443.6367,910.2675,494.3984,671.5774,767.5973,032.1933,643.1253,824.1153,747.6793,704.1913,388.6413,306.4573,244.4033,066.8672,993.5723,517.8963,580.6463,658.8512,101.085
Other Expenses 3,278.87600-182.529-8.066-15,228.235-14,893.465-1,150.93,122.8161,733.441,967.7142,024.339185.352182.804186.294379.885-176.521233.388263.64398.62139.597389.395365.877161.408202.103209.5651,813.8215.71484.486160.99259.525
Operating Expenses 12,615.78511,421.79110,021.7239,511.8958,050.075-7,614.117-7,446.7328,096.10610,998.36812,481.64713,130.91614,395.07414,710.50210,438.7378,176.9517,516.8578,680.3415,349.2956,172.6186,442.5347,684.9176,050.0555,822.6446,037.8657,427.5595,279.2555,414.9235,996.5537,495.5985,771.2183,552.169
Operating Income 13,193.46316,272.48416,741.59412,559.5786,226.8336,057.0786,640.7143,602.538-1,911.32530,567.53327,715.57621,597.25220,636.5630,264.04426,272.57617,858.93710,916.8311,677.40816,332.84810,340.6628,278.15112,550.04115,010.7710,749.044,662.22112,281.07414,004.4719,083.2574,021.14512,133.1065,659.285
Operating Income Ratio 0.1040.1270.1290.1010.0610.0540.0590.032-0.0140.2210.1580.1350.1450.2130.2020.1540.110.1360.1780.1090.0910.1370.1530.110.0530.1320.1510.1050.0540.140.12
Total Other Income Expenses Net 8,433.639-1,753.2672,686.9393,835.623267.2071,749.316-2,351.5684,820.92-12,742.3139,197.2244,944.2432,643.75339.3215,710.281618.2953,798.586-7,178.468-353.271-836.2674,895.168-2,242.7221,634.1221,969.7671,280.289288.468-268.2113,834.519789.843-3,639.4851,286.138962.53
Income Before Tax 21,627.10214,519.21719,428.53316,395.2016,494.047,806.3944,289.1468,423.458-2,486.54830,482.0832,659.81924,241.00220,975.88135,974.32626,890.87121,657.5243,738.36211,324.13615,496.58115,295.3966,035.42914,184.16316,980.53712,029.3294,950.68812,012.86317,838.999,873.098381.65913,419.2446,621.815
Income Before Tax Ratio 0.1710.1130.150.1320.0640.0690.0380.076-0.0180.220.1860.1510.1470.2530.2060.1860.0380.1320.1690.1610.0670.1550.1730.1230.0560.1290.1930.1140.0050.1550.14
Income Tax Expense 7,989.8132,412.914,335.1212,665.3542,718.3062,039.0031,736.8651,914.224-938.6477,503.3119,850.5144,954.55,714.7998,516.2756,335.3125,028.85659.6013,267.9723,659.1744,142.511,626.1852,644.1922,616.452,777.328100.1153,108.4072,971.1352,521.903-1,037.8552,808.8791,454.76
Net Income 13,637.28912,106.30715,093.41213,729.8463,775.7345,767.3922,552.2816,509.234-1,547.90122,978.76922,809.30519,286.50215,261.08227,458.05120,555.5616,628.6683,678.7618,056.16511,837.40711,152.8874,409.24411,539.97214,364.0889,252.0014,850.5738,904.45614,867.8567,351.1951,419.51610,610.3645,167.055
Net Income Ratio 0.1080.0940.1160.110.0370.0510.0230.059-0.0110.1660.130.120.1070.1930.1580.1430.0370.0940.1290.1170.0490.1260.1470.0940.0550.0960.160.0850.0190.1230.109
EPS 2,792.52,4793,090.442,830.11766.941,190.83512.641,301.57-309.214,5824,548.223,8463,043.544,0834,0833,295721.332,3162,3162,1408372,1912,7491,772934.261,7152,8711,419274.122,049998
EPS Diluted 2,792.52,4793,090.442,830.11766.941,190.83512.641,301.57-309.214,581.674,548.223,845.763,043.544,0834,0833,295721.332,3162,3162,1408372,1912,7491,772934.261,7152,8711,419274.122,049998
EBITDA 29,066.79721,845.8926,946.00423,407.23714,371.31415,651.96613,583.30815,429.6793,348.55535,961.5133,083.59228,794.92925,117.16940,242.71630,460.03522,043.20815,117.73515,828.73320,488.68119,364.29912,813.18716,536.37618,993.01914,098.2648,309.2915,925.69917,624.23312,735.0833,249.44716,317.4166,671.141
EBITDA Ratio 0.230.170.2080.1880.1420.1390.120.1390.0240.260.1880.1790.1760.2830.2340.1890.1530.1840.2230.2040.1410.1810.1940.1440.0940.1710.190.1470.0440.1890.141